Skip to main content

Table 1

From: High-dose chemotherapy with peripheral blood progenitor cell support in breast cancer: WSG AM01 and MM01

 

AM 01

MM01

Patients

Adjuvant N>9

M1, PR or CR after conventional

  

   induction, ER

Arm A

Tandem-E,C,TT

STAMP V

Arm B

EC ×4 → CMF ×3

Tandem STAMP V

 

   q2w + G-CSF

 

Actually randomized

368

180/480

Status

Open

Open

Treatment related

0%

1.5%

   mortality (%)